Frontal lobe dysfunction in secondary depression.
暂无分享,去创建一个
[1] R. Mayeux,et al. Clinical and biochemical features of depression in Parkinson's disease. , 1986, The American journal of psychiatry.
[2] A. Dray. Serotonin in the basal ganglia: functions and interactions with other neuronal pathways. , 1981, Journal de physiologie.
[3] W. Jagust,et al. Cognitive function and regional cerebral blood flow in Parkinson's disease. , 1992, Brain : a journal of neurology.
[4] J. Morris,et al. The association of ventral tegmental area histopathology with adult dementia. , 1988, Archives of neurology.
[5] I. Shoulson,et al. Psychiatric syndromes in Huntington's disease. , 1983, The American journal of psychiatry.
[6] J R Moeller,et al. Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest. , 1990, Archives of general psychiatry.
[7] J. Penney,et al. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. , 1990, The New England journal of medicine.
[8] J. Penney,et al. NMDA receptor losses in putamen from patients with Huntington's disease. , 1988, Science.
[9] C. Markham,et al. Cerebral metabolism and atrophy in huntington's disease determined by 18FDG and computed tomographic scan , 1982, Annals of neurology.
[10] J. W. Papez. A PROPOSED MECHANISM OF EMOTION , 1937 .
[11] L. Lazarus,et al. Frequency and presentation of depressive symptoms in patients with primary degenerative dementia. , 1987, The American journal of psychiatry.
[12] J S Fowler,et al. Changes in brain glucose metabolism in cocaine dependence and withdrawal. , 1991, The American journal of psychiatry.
[13] H. Mayberg,et al. Depression and cognitive impairment in Parkinson's disease. , 1989, Brain : a journal of neurology.
[14] M. Raichle,et al. A functional anatomical study of unipolar depression , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[15] R. J. Roberts,et al. Neuropsychological performance in lateralized parkinsonism. , 1988, Archives of neurology.
[16] N. Alpert,et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. , 1994, Archives of general psychiatry.
[17] K. E. Moore,et al. Destruction of dopaminergic nerve terminals in nucleus accumbens: Effect on d-amphetamine self-administration , 1979, Pharmacology Biochemistry and Behavior.
[18] K. Davis,et al. Overview: toward a dysregulation hypothesis of depression. , 1985, The American journal of psychiatry.
[19] R. Mutani,et al. Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[20] P. Fedio,et al. Quantitative analysis of interictal behavior in temporal lobe epilepsy. , 1977, Archives of neurology.
[21] D. Kaloupek,et al. Poststroke depression and lesion location. An attempted replication. , 1986, Brain : a journal of neurology.
[22] P. Goldman-Rakic,et al. Direct and indirect pathways from the amygdala to the frontal lobe in rhesus monkeys , 1981, The Journal of comparative neurology.
[23] Marcus E. Raichle,et al. Regional blood flow in herniparkinsonism , 1985, Neurology.
[24] W. Jagust,et al. Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia. , 1989, American journal of physiologic imaging.
[25] A. Phillips,et al. The role of dopamine in maintaining intracranial self-stimulation in the ventral tegmentum, nucleus accumbens, and medial prefrontal cortex. , 1978, Canadian journal of psychology.
[26] W. Nauta,et al. Afferent and efferent relationships of the basal ganglia. , 1984, Ciba Foundation symposium.
[27] D. Bear. Hemispheric specialization and the neurology of emotion. , 1983, Archives of neurology.
[28] B. Reisberg,et al. Positron emission tomography in dementia. , 1983, Advances in neurology.
[29] J. Schildkraut,et al. The catecholamine hypothesis of affective disorders: a review of supporting evidence. , 1965, The American journal of psychiatry.
[30] Van Praag Hm. Serotonin precursors in the treatment of depression. , 1982 .
[31] R G Robinson,et al. Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. , 1987, Brain : a journal of neurology.
[32] Karl J. Friston,et al. Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[33] T Jones,et al. Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease , 1985, Neurology.
[34] H N Wagner,et al. Paralimbic hypoperfusion in unipolar depression. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[35] R. Mindham. Psychiatric symptoms in Parkinsonism. , 1970, Journal of neurology, neurosurgery, and psychiatry.
[36] R. Hichwa,et al. Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function , 1988, Annals of neurology.
[37] G. Sedvall,et al. Imaging of neurotransmitter receptors in the living human brain. , 1986, Archives of general psychiatry.
[38] S. Yudofsky. Parkinson's disease, depression, and electroconvulsive therapy: a clinical and neurobiologic synthesis. , 1979, Comprehensive psychiatry.
[39] R. Frackowiak,et al. Quantitative Measurement of Regional Cerebral Blood Flow and Oxygen Metabolism in Man Using 15O and Positron Emission Tomography: Theory, Procedure, and Normal Values , 1980, Journal of computer assisted tomography.
[40] M. Cassell,et al. Topography of projections from the medial prefrontal cortex to the amygdala in the rat , 1986, Brain Research Bulletin.
[41] Y Agid,et al. Is the mesocortical dopaminergic system involved in Parkinson disease? , 1980, Neurology.
[42] C D Marsden,et al. Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography , 1986, Movement disorders : official journal of the Movement Disorder Society.
[43] W. Weiner,et al. Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[44] C. Nemeroff. Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal. , 1989, The Journal of clinical psychiatry.
[45] T. Dening,et al. Wilson's disease. Psychiatric symptoms in 195 cases. , 1989, Archives of general psychiatry.
[46] Ferrell Rb,et al. Multiple sclerosis--presenting as depressive illness. , 1977 .
[47] M. Buyse,et al. Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid , 1990, Acta neurologica Scandinavica.
[48] J. Moossy,et al. Neurochemical correlates of major depression in primary dementia. , 1990, Archives of neurology.
[49] J. Cummings,et al. Noncognitive neuropsychiatric syndromes in alzheimer’s disease , 1990 .
[50] H. E. Rosvold,et al. Analysis of the delayed-alternation deficit produced by dorsolateral prefrontal lesions in the rhesus monkey. , 1971, Journal of comparative and physiological psychology.
[51] Hervé Simon,et al. Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [3H]leucine and horseradish peroxidase , 1979, Brain Research.
[52] Pierre Fler-Henry. Psychosis and temporal lobe epilepsy , 1966 .
[53] J. Korf,et al. Dopamine metabolism in depressions, psychoses, and Parkinson's disease: the problem of the specificity of biological variables in behaviour disorders , 1975, Psychological Medicine.
[54] S. Iversen,et al. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum , 1975, Brain Research.
[55] R. Mendius,et al. Depression and Anxiety in Complex Partial Seizures , 1984, The Journal of nervous and mental disease.
[56] B Mazoyer,et al. Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study. , 1989, Brain : a journal of neurology.
[57] H. Herzog,et al. Cerebral glucose consumption measured by PET in patients with and without psychiatric symptoms of Huntington's disease , 1989, Psychiatry Research.
[58] W. Nauta. The problem of the frontal lobe: a reinterpretation. , 1971, Journal of psychiatric research.
[59] H. E. Rosvold,et al. Behavioral effects of selective ablation of the caudate nucleus. , 1967, Journal of comparative and physiological psychology.
[60] A J Rush,et al. Diagnosis and neuroanatomical correlates of depression in brain-damaged patients. Implications for a neurology of depression. , 1981, Archives of general psychiatry.
[61] G. E. Alexander,et al. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. , 1990, Progress in brain research.
[62] M. Hayden,et al. Positron emission tomography in the early diagnosis of Huntington's disease , 1986, Neurology.
[63] R Harrop,et al. Cerebral Glucose Metabolism in Parkinson’s Disease , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[64] H. Fibiger. The Neurobiological Substrates of Depression in Parkinson’s Disease: A Hypothesis , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[65] J. Mendelson,et al. A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[66] Y. Agid,et al. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease , 1983, Brain Research.
[67] J. Saint-Cyr,et al. Idiopathic Parkinson's disease: Revised Concepts of Cognitive and Affective Status , 1988, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[68] M S Buchsbaum,et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. , 1986, Journal of affective disorders.
[69] L. Sokoloff,et al. Localization of Functional Activity in the Central Nervous System by Measurement of Glucose Utilization with Radioactive Deoxyglucose , 1981, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[70] Peter Herscovitch,et al. A focal brain abnormality in panic disorder, a severe form of anxiety , 1984, Nature.
[71] J. Saint-Cyr,et al. Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. , 1986, Brain : a journal of neurology.
[72] R. Mayeux,et al. The relationship of serotonin to depression in Parkinson's disease , 1988, Movement disorders : official journal of the Movement Disorder Society.
[73] S. Folstein,et al. Huntington's disease as a model for mood disorders. Clues from neuropathology and neurochemistry. , 1990, Molecular and chemical neuropathology.
[74] Karl J. Friston,et al. The anatomy of melancholia – focal abnormalities of cerebral blood flow in major depression , 1992, Psychological Medicine.
[75] L. Price,et al. Serotonergic dysfunction in depression associated with Parkinson's disease , 1992, Neurology.
[76] M. Myslobodsky,et al. Does unilateral dopamine deficit contribute to depression? , 1985, Psychiatry Research.
[77] Mario F. Mendez,et al. Neurobehavioral changes associated with caudate lesions , 1989, Neurology.
[78] A. Coppen,et al. Levodopa and L-tryptophan therapy in Parkinsonism. , 1972, Lancet.
[79] M. Albert,et al. The `subcortical dementia' of progressive supranuclear palsy , 1974, Journal of neurology, neurosurgery, and psychiatry.
[80] R. Mayeux,et al. Coexisting dementia and depression in Parkinson's disease. , 1989, Archives of neurology.
[81] J. Cummings. Depression and Parkinson's disease: a review. , 1992, The American journal of psychiatry.
[82] K. Jellinger,et al. Overview of morphological changes in Parkinson's disease. , 1987, Advances in neurology.
[83] J M Hoffman,et al. Clinical application of PET for the evaluation of brain tumors. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[84] S. Pappatà,et al. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. , 1990, The American journal of psychiatry.
[85] W. Matthews. Multiple sclerosis presenting with acute remitting psychiatric symptoms. , 1979, Journal of neurology, neurosurgery, and psychiatry.
[86] A. Alavi,et al. The [18F]Fluorodeoxyglucose Method for the Measurement of Local Cerebral Glucose Utilization in Mane , 1979, Circulation research.
[87] J. Coyle,et al. Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease. , 1981, Biological psychiatry.
[88] A J Lees,et al. Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study. , 1987, Brain : a journal of neurology.
[89] E. Hoffman,et al. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.
[90] A. Hietaharju,et al. Nervous system manifestations in Sjögren's syndrome , 1990, Acta neurologica Scandinavica.
[91] T. Budinger,et al. Evaluation of Blood — Brain Barrier Permeability Changes in Rhesus Monkeys and Man Using 82Rb and Positron Emission Tomography , 1981, Journal of computer assisted tomography.
[92] G. Aghajanian,et al. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.
[93] J. Mendlewicz,et al. Regional Cerebral Blood Flow in Patients with Affective Disorders , 1990, British Journal of Psychiatry.
[94] S. Folstein,et al. The association of affective disorder with Huntington's Disease in a case series and in families , 1983, Psychological Medicine.
[95] W. Lishman,et al. Brain Damage in Relation to Psychiatric Disability After Head Injury , 1968, British Journal of Psychiatry.
[96] T. Chase,et al. Release of [3H]dopamine byl-5-hydroxytryptophan , 1972 .
[97] R. Robinson,et al. Specificity of affective and autonomic symptoms of depression in Parkinson's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.
[98] J. Mazziotta,et al. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. , 1988, The American journal of psychiatry.
[99] R. Hichwa,et al. PET scan investigations of Huntington's disease: Cerebral metabolic correlates of neurological features and functional decline , 1986, Annals of neurology.
[100] R. Robinson,et al. Mood disorders in stroke patients. Importance of location of lesion. , 1984, Brain : a journal of neurology.
[101] G L Wolf,et al. Brain imaging abnormalities in mental disorders of late life. , 1990, Archives of neurology.
[102] M. Trimble,et al. Phenomenology of Depression in Epilepsy , 1987, Epilepsia.
[103] Judith M. Rumsey,et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. , 1990 .
[104] J. Andersen,et al. Anti‐depressive treatment in Parkinson's disease A CONTROLLED TRIAL OF THE EFFECT OF NORTRIPTYLINE IN PATIENTS WITH PARKINSON'S DISEASE TREATED WITH L‐DOPA , 1980, Acta neurologica Scandinavica.
[105] P. Stark,et al. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder. , 1985, The Journal of clinical psychiatry.
[106] H. Weingartner,et al. The effects of lateralized frontal lesions on mood regulation. , 1986, Brain : a journal of neurology.
[107] J S Fowler,et al. Decreased brain metabolism in neurologically intact healthy alcoholics. , 1992, The American journal of psychiatry.
[108] L. Altshuler,et al. Depression, anxiety, and temporal lobe epilepsy. Laterality of focus and symptoms. , 1990, Archives of neurology.
[109] M. Ichise,et al. Technetium-99m-HMPAO SPECT, CT and MRI in the evaluation of patients with chronic traumatic brain injury: a correlation with neuropsychological performance. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[110] H. Mayberg,et al. Depression in Parkinson's disease: a biochemical and organic viewpoint. , 1995, Advances in neurology.
[111] Karl J. Friston,et al. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions , 1993, Psychological Medicine.
[112] G. Paulson,et al. Neuropsychological Similarities in Lateralized Parkinsonism , 1989, Cortex.
[113] H N Wagner,et al. Mania after brain injury: Neuroradiological and metabolic findings , 1990, Annals of neurology.
[114] G. Gainotti. Emotional behavior and hemispheric side of the lesion. , 1972, Cortex; a journal devoted to the study of the nervous system and behavior.
[115] E. Metter,et al. Subcortical structures in aphasia. An analysis based on (F-18)-fluorodeoxyglucose, positron emission tomography, and computed tomography. , 1988, Archives of neurology.
[116] M. Devous,et al. Functional brain SPECT: the emergence of a powerful clinical method. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[117] J. Baron. Depression of Energy Metabolism in Distant Brain Structures: Studies with Positron Emission Tomography in Stroke Patients , 1989, Seminars in neurology.
[118] G. E. Alexander,et al. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.
[119] David E. Kuhl,et al. Journal of Cerebral Blood Flow and Metabolism Cerebral Metabolic Relationships for Selected Brain Regions in Alzheimer's, Huntington's, and Parkinson's Diseases , 2022 .
[120] G. Alexopoulos,et al. Dissociation of motor response from mood and cognition in a Parkinsonian patient treated with ECT , 1985, Biological Psychiatry.
[121] D Comar,et al. Noninvasive tomographic study of cerebral blood flow and oxygen metabolism in vivo. Potentials, limitations, and clinical applications in cerebral ischemic disorders. , 1981, European neurology.
[122] M S Buchsbaum,et al. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. , 1990, Schizophrenia bulletin.
[123] Joseph B. Martin,et al. Neuropeptides in neurological disease , 1986, Annals of neurology.
[124] R G Robinson,et al. Differential mood changes following basal ganglia vs thalamic lesions. , 1988, Archives of neurology.
[125] R. Mayeux,et al. Depression, intellectual impairment, and Parkinson disease , 1981, Neurology.
[126] P. Goldman-Rakic,et al. Topography of Corticostriatal Projections in Nonhuman Primates and Implications for Functional Parcellation of the Neostriatum , 1986 .
[127] K. Welch,et al. Disordered neurotransmitter function. Demonstration by measurement of norepinephrine and 5-hydroxytryptamine in CSF of patients with recent cerebral infarction. , 1974, Brain : a journal of neurology.
[128] N. Geschwind,et al. Hemispheric asymmetry in the expression of positive and negative emotions. Neurologic evidence. , 1982, Archives of neurology.
[129] H. Mayberg,et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease , 1990, Annals of neurology.
[130] R. Omdal,et al. Clinical neuropsychiatric and neuromuscular manifestations in systemic lupus erythematosus. , 1988, Scandinavian journal of rheumatology.
[131] J. Penney,et al. The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.
[132] PET-based neuropharmacology: state of the art. , 1989, Cerebrovascular and brain metabolism reviews.
[133] W. Honer,et al. Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. , 1987, Archives of neurology.
[134] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[135] R. Gur,et al. Laterality and frontality of cerebral blood flow and metabolism in schizophrenia: Relationship to symptom specificity , 1989, Psychiatry Research.
[136] S. Folstein,et al. Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease , 1992, Neurology.
[137] C D Marsden,et al. Depression in Parkinson's disease: a quantitative and qualitative analysis. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[138] R G Robinson,et al. Depression in Parkinson's Disease , 1990, The Journal of nervous and mental disease.
[139] E. Azmitia,et al. The primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis. , 1986, Advances in neurology.
[140] R. S. Williams,et al. Morphometric analysis of the prefrontal cortex in Huntington's disease , 1991, Neurology.
[141] R G Robinson,et al. Two-year longitudinal study of post-stroke mood disorders: dynamic changes in correlates of depression at one and two years. , 1987, Stroke.
[142] L. DeLisi,et al. Glucose utilization in the temporal cortex of affectively ill patients: Positron emission tomography , 1987, Biological Psychiatry.
[143] D E Kuhl,et al. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method , 1984, Annals of neurology.
[144] L. Berg,et al. Preliminary report on affective symptoms in the early stages of senile dementia of the Alzheimer type. , 1983, The American journal of psychiatry.
[145] D L Price,et al. Parkinson's disease , 1985, Neurology.
[146] J. Mazziotta,et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. , 1989, Archives of general psychiatry.
[147] Y Agid,et al. Biochemistry of Parkinson's disease 28 years later: A critical review , 1989, Movement disorders : official journal of the Movement Disorder Society.
[148] R. Wise. Catecholamine theories of reward: A critical review , 1978, Brain Research.
[149] A. Damasio,et al. Severe disturbance of higher cognition after bilateral frontal lobe ablation , 1985, Neurology.